ID30250A - Kemoterapi kombinasi - Google Patents

Kemoterapi kombinasi

Info

Publication number
ID30250A
ID30250A IDW00200101616A ID20011616A ID30250A ID 30250 A ID30250 A ID 30250A ID W00200101616 A IDW00200101616 A ID W00200101616A ID 20011616 A ID20011616 A ID 20011616A ID 30250 A ID30250 A ID 30250A
Authority
ID
Indonesia
Prior art keywords
combination chemotherapy
chemotherapy
combination
Prior art date
Application number
IDW00200101616A
Other languages
English (en)
Indonesian (id)
Inventor
Richard Car Ton Gowan
Judith S-Leopold
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ID30250A publication Critical patent/ID30250A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IDW00200101616A 1998-12-22 1999-12-21 Kemoterapi kombinasi ID30250A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11329198P 1998-12-22 1998-12-22
US16478899P 1999-11-10 1999-11-10

Publications (1)

Publication Number Publication Date
ID30250A true ID30250A (id) 2001-11-15

Family

ID=26810891

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101616A ID30250A (id) 1998-12-22 1999-12-21 Kemoterapi kombinasi

Country Status (31)

Country Link
EP (1) EP1140291B1 (xx)
JP (1) JP2002532570A (xx)
KR (1) KR20010099877A (xx)
CN (1) CN1333698A (xx)
AP (1) AP2001002175A0 (xx)
AT (1) ATE310567T1 (xx)
AU (1) AU2203900A (xx)
BG (1) BG105715A (xx)
BR (1) BR9916839A (xx)
CA (1) CA2352326A1 (xx)
CZ (1) CZ20012139A3 (xx)
DE (1) DE69928568T2 (xx)
EA (1) EA200100687A1 (xx)
EE (1) EE200100339A (xx)
ES (1) ES2253928T3 (xx)
GE (1) GEP20043172B (xx)
HK (1) HK1042057A1 (xx)
HR (1) HRP20010473A2 (xx)
HU (1) HUP0104844A3 (xx)
ID (1) ID30250A (xx)
IL (1) IL143939A0 (xx)
IS (1) IS5969A (xx)
MA (1) MA26768A1 (xx)
NO (1) NO20013099L (xx)
NZ (1) NZ512859A (xx)
OA (1) OA11733A (xx)
PL (1) PL348326A1 (xx)
SK (1) SK8712001A3 (xx)
TR (1) TR200101871T2 (xx)
WO (1) WO2000037141A1 (xx)
YU (1) YU45401A (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20053496B (en) * 2000-07-19 2005-04-25 Warner Lambert Co Oxygenated Esters of 4-Iodo Phenylamino Benzhydroxamic Acids
AU8856201A (en) 2000-09-01 2002-03-13 Andel Inst Van Inhibition of mitogen-activated protein kinase (mapk) pathway: a selective therapeutic strategy against melanoma
CA2442015A1 (en) * 2001-03-22 2002-10-03 Van Andel Institute Anthrax lethal factor inhibits tumor growth and angiogenesis
NZ518726A (en) 2001-05-09 2004-06-25 Warner Lambert Co Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
JPWO2005035493A1 (ja) * 2003-10-08 2006-12-21 帝人ファーマ株式会社 アミノピロリジン誘導体の製造方法および中間体化合物
AU2004283148A1 (en) 2003-10-21 2005-05-06 Warner-Lambert Company Llc Polymorphic form of N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
JP5214971B2 (ja) 2004-10-20 2013-06-19 メルク セローノ ソシエテ アノニム 3−アリルアミノピペリジン誘導体
CN1807413B (zh) * 2005-09-28 2010-05-05 中国医学科学院医药生物技术研究所 咔唑磺酰胺衍生物及其制备方法
JP5129143B2 (ja) 2005-10-07 2013-01-23 エグゼリクシス, インコーポレイテッド Mekインヒビターおよびその使用方法
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
EP1957487A1 (de) 2005-11-11 2008-08-20 AEterna Zentaris GmbH Neue pyridopyrazine und deren verwendung als modulatoren von kinasen
CN101605540A (zh) 2006-12-14 2009-12-16 埃克塞利希斯股份有限公司 使用mek抑制剂的方法
US9084781B2 (en) 2008-12-10 2015-07-21 Novartis Ag MEK mutations conferring resistance to MEK inhibitors
CA2789696C (en) 2010-02-25 2017-11-07 Dana-Farber Cancer Institute, Inc. Braf mutations conferring resistance to braf inhibitors
JP5985401B2 (ja) 2010-03-09 2016-09-06 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド 第一の癌療法に対する耐性を現に有するか、または、そのような耐性を生じる患者において癌を診断および治療する方法
CN103301096B (zh) * 2012-03-14 2015-05-06 中国中化股份有限公司 取代二苯胺类化合物作为制备抗肿瘤药物的应用
WO2013169858A1 (en) 2012-05-08 2013-11-14 The Broad Institute, Inc. Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
SI2909188T1 (en) 2012-10-12 2018-07-31 Exelixis, Inc. A novel process for the manufacture of compounds for use in the treatment of cancer
ES2703208T3 (es) 2013-02-27 2019-03-07 Daiichi Sankyo Co Ltd Método de predicción de la sensibilidad a un compuesto que inhibe la vía de transducción de señales de MAPK
CN105384754B (zh) * 2014-09-02 2018-04-20 上海科州药物研发有限公司 作为蛋白激酶抑制剂的杂环类化合物及其制备方法和用途
CN111909053B (zh) * 2020-08-06 2022-12-06 湖北省生物农药工程研究中心 基于二芳胺单元的酰胺类衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112248A0 (en) * 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
AU2092597A (en) * 1996-03-07 1997-09-22 Novartis Ag Antiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds
US6251943B1 (en) * 1997-02-28 2001-06-26 Warner-Lambert Company Method of treating or preventing septic shock by administering a MEK inhibitor
CA2284685A1 (en) * 1997-03-21 1998-10-01 Board Of Regents, The University Of Texas System Noey2 gene compositions and methods of use
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
US5959097A (en) * 1998-11-20 1999-09-28 Isis Pharmaceuticals, Inc. Antisense modulation of MEK2 expression

Also Published As

Publication number Publication date
DE69928568T2 (de) 2006-07-27
OA11733A (en) 2005-05-12
BG105715A (en) 2002-04-30
IS5969A (is) 2001-06-14
NO20013099D0 (no) 2001-06-21
GEP20043172B (en) 2004-02-25
HUP0104844A2 (en) 2002-06-29
EP1140291B1 (en) 2005-11-23
WO2000037141A1 (en) 2000-06-29
ATE310567T1 (de) 2005-12-15
MA26768A1 (fr) 2004-12-20
CN1333698A (zh) 2002-01-30
DE69928568D1 (de) 2005-12-29
EE200100339A (et) 2002-10-15
KR20010099877A (ko) 2001-11-09
EP1140291A1 (en) 2001-10-10
AU2203900A (en) 2000-07-12
IL143939A0 (en) 2002-04-21
HK1042057A1 (zh) 2002-08-02
NO20013099L (no) 2001-08-20
HUP0104844A3 (en) 2003-05-28
PL348326A1 (en) 2002-05-20
NZ512859A (en) 2004-06-25
ES2253928T3 (es) 2006-06-01
SK8712001A3 (en) 2002-02-05
AP2001002175A0 (en) 2001-06-21
HRP20010473A2 (en) 2002-08-31
YU45401A (sh) 2004-07-15
TR200101871T2 (tr) 2001-10-22
BR9916839A (pt) 2001-10-09
EA200100687A1 (ru) 2001-12-24
WO2000037141A9 (en) 2000-12-07
JP2002532570A (ja) 2002-10-02
CZ20012139A3 (cs) 2002-01-16
CA2352326A1 (en) 2000-06-29

Similar Documents

Publication Publication Date Title
DE69917956D1 (de) Tintenzuführsystemadapter
DE69916556D1 (de) Bohrhülsensysteme
NO20011191D0 (no) Vedlikeholdsfrigivelses-ranolazinformuleringer
DE59902874D1 (de) Buchsenkontakt
IS5585A (is) Lyfjaskömmtunarbúnaðir
DE69924838D1 (de) Einlasslufterhitzmodule
FI980536A (fi) Kokoonpanolinja
NO20013099D0 (no) Kombinasjonskjemoterapi
DE69933073D1 (de) Informationsaufzeichnungsträgercassette
DE69902762D1 (de) Riser-spannanordnung
ID24221A (id) Tempat patrum
DE69811890D1 (de) Einzellenkalorimeter
DE69940418D1 (de) Tonsignalsmischung
FI980564A0 (fi) Volymregleringsorgan foer stroemningsroer
DE69941474D1 (de) Lichtstrahlabtastgerät
DE69924068D1 (de) Gasfederfüllventil
FI980251A0 (fi) Breddstraeckvals
DE69942000D1 (de) Sicherheitstontaube
DE69808524T2 (de) Refinerplattensegment
ATA32198A (de) Beschlag
DE59911641D1 (de) Radaufhängungs-tester
NO20010996D0 (no) 2-okso-2H-kinolinderivater
ATA30898A (de) Beschlag
SE9902890D0 (sv) Golvrelaterat arrangemang
ES1045442Y (es) Preservapie